News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
186 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37189)
2018 (39119)
2019 (51336)
2020 (57664)
2021 (58721)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (14380)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Appili Therapeutics Appoints Seasoned Biotech Executive Ian C. Mortimer to its Board
Mr. Mortimer is a seasoned biotechnology executive with proven abilities in leading capital market transactions. He will serve as chair of Appili’s audit committee.
November 28, 2017
·
2 min read
Business
Vir Biotechnology Appoints Herbert W. “Skip” Virgin Executive Vice President and Chief Scientific Officer
The appointment is effective January 1, 2018.
November 28, 2017
·
4 min read
BioMidwest
Importance of Quantitative Analysis in Breast Imaging Highlighted in Clinical and Research Results Presented at RSNA
Four abstracts highlighted the use of Volpara’s quantitative analysis tools for breast imaging.
November 28, 2017
·
4 min read
Drug Development
Merck KGaA, Pfizer’s Bavencio Flunks Late-Stage Gastric Cancer Trial
The safety profile of avelumab was consistent with that observed in the overall JAVELIN clinical development program.
November 28, 2017
·
12 min read
Biotech Bay
Omnicell Introduces Revolutionary New Solution to Automate Critical Workflows in Central Pharmacy
The Omnicell XR2 Automated Central Pharmacy System, designed with input from leading health system pharmacies, streamlines critical workflows to maximize inventory control, improve operational efficiency, and increase medication safety.
November 28, 2017
·
3 min read
BioMidwest
Medizone to Meet With FDA Regarding the AsepticSure Disinfection System, a Revolutionary Disinfection Technology
Medizone today announced that it will meet with representatives of the FDA on January 18, 2018 to discuss the planned submission of a marketing application for AsepticSure.
November 28, 2017
·
2 min read
Business
Genomic Health and Cleveland Diagnostics Announce Strategic Collaboration to Develop and Commercialize New Prostate Cancer Tests
Initial efforts under this agreement will focus on Genomic Health’s development of a high-PSA reflex test to accurately predict the presence of high-grade cancer prior to prostate biopsy.
November 28, 2017
·
9 min read
Business
X-Chem and Gilead Announce Drug Discovery Collaboration
Agreement leverages X-Chem’s DEX DNA-Encoded Libraries and Gilead’s proprietary know-how to enable the discovery of new chemical entities.
November 28, 2017
·
3 min read
Drug Development
Enrollment Completed in Flex Pharma’s Phase II Exploratory Spasticity Study in MS
The randomized, placebo-controlled, blinded, cross-over study is designed to evaluate the safety and efficacy of FLX-787.
November 28, 2017
·
5 min read
Bio NC
IQVIA Announces Pricing of Secondary Public Offering
The Repurchase will be completed outside IQVIA’s existing share repurchase program, under which IQVIA has approximately $195 million of remaining availability.
November 28, 2017
·
3 min read
Previous
3 of 19
Next